Join
Live feed
·
PRReleasevia Quantisnow
Sangamo Therapeutics Inc. logo

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease

ByQuantisnow·Wall Street's wire, on your screen.
SGMO· Sangamo Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGMO (Sangamo Therapeutics Inc.) and more on Quantisnow.